Tag Archives: BIO Events

Liking, Sharing, and Tweeting to Better Health

BIO2014 Panel

Making an impact online goes beyond having a Facebook page. Helping to open the 2014 BIO International Convention, Amy O’Conner, Director, Digital Government Affairs with Eli Lilly and Company, joined Chief Marketing Officer at POPVOX, Rachna Choudhry; Twitter’s Head of Healthcare, Jeremy Anderson; and Chief Strategist at Pure Communications, Mike Huckman, to discuss how social media can empower individuals and patient advocates to improve the future of health care. O’Conner writes: “Part of what makes Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Expand Investment in Basic Research Needed to Advance Medical Progress

Michael Coburn

In 2007, the Napier and Lane families struggled to find answers to their daughters’ developmental problems, which included impaired communication and socialization skills. Both of the girls had a disorder so rare that it subsequently became identified only by the name of the small fragment of chromosome 16 that was missing, namely “16p11.2 deletion syndrome.” Dan Pinkel and Joe Gray, researchers at the University of California, San Francisco developed microarray comparative genomic hybridization, a technology Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

From Participant to Judge in the International BioGENEius Challenge

Sagar

My name is Sagar Rambhia, and I participated in the 2011 International BioGENEius Challenge. Three years later, I have come back to be a judge at the 2014 International BioGENEius Challenge. I am 19 years old, and since competing in the 2011 BioGENEius Challenge, I have started my own company and continued to conduct biomedical engineering research. Back in 2011, as part of the BioGENEius Challenge, I was given the life-changing opportunity to present my Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New Type of Prospective Survey Initiative

scientist-eyedropper

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating and life-threatening diseases. To help advance innovation and promote the development of the next generation of treatments and cures, we must acknowledge that the scientific method does not operate in a vacuum. Robust, interactive FDA-Sponsor communication is a key element of modern drug development. However, in order to improve the drug development enterprise and the FDA review process further, the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Acts of Support

hahn

Because small biotechnology companies do not have product revenue, burdensome regulations have an outsized effect on them. One-size-fits-all compliance requirements – such as Section 404(b) of the Sarbanes-Oxley Act (SOX) – divert funds from the lab and slow the development process. We have already seen the benefits that positive legislative reform can have for capital formation for emerging growth companies (EGCs). The JOBS Act has led to a sea change in the regulatory landscape and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,